Abraham Avigdor

761 total citations
14 papers, 426 citations indexed

About

Abraham Avigdor is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Abraham Avigdor has authored 14 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Abraham Avigdor's work include Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Abraham Avigdor is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Abraham Avigdor collaborates with scholars based in Israel and United States. Abraham Avigdor's co-authors include Isaac Ben‐Bassat, Arnon Nagler, Izhar Hardan, Elinor Goshen, Tima Davidson, Itai Levi, Moshe Yeshurun, Avichai Shimoni, Orly Goitein and S. Tzila Zwas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and American Journal of Roentgenology.

In The Last Decade

Abraham Avigdor

14 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abraham Avigdor Israel	10	168	133	111	108	76	14	426
Mariko Yabe United States	14	199 1.2×	142 1.1×	128 1.2×	65 0.6×	138 1.8×	39	466
Hideyuki Koharazawa Japan	12	96 0.6×	115 0.9×	191 1.7×	42 0.4×	80 1.1×	40	405
Leanne Berkahn New Zealand	12	255 1.5×	150 1.1×	86 0.8×	44 0.4×	128 1.7×	36	474
Guido Gini Italy	12	241 1.4×	210 1.6×	184 1.7×	33 0.3×	93 1.2×	37	629
Roswitha Dickerhoff Germany	12	155 0.9×	114 0.9×	245 2.2×	48 0.4×	96 1.3×	37	556
T. Girinsky France	12	128 0.8×	250 1.9×	182 1.6×	100 0.9×	59 0.8×	22	574
Muhamad Alhaj Moustafa United States	10	106 0.6×	121 0.9×	88 0.8×	50 0.5×	79 1.0×	89	315
Caroline Kuhlman United States	8	338 2.0×	301 2.3×	135 1.2×	38 0.4×	130 1.7×	12	596
Bicky Thapa United States	13	81 0.5×	244 1.8×	89 0.8×	101 0.9×	67 0.9×	51	441
Sudha Parasuraman United States	8	78 0.5×	102 0.8×	96 0.9×	38 0.4×	69 0.9×	15	304

Countries citing papers authored by Abraham Avigdor

Since Specialization

Citations

This map shows the geographic impact of Abraham Avigdor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Avigdor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Avigdor more than expected).

Fields of papers citing papers by Abraham Avigdor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham Avigdor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Avigdor. The network helps show where Abraham Avigdor may publish in the future.

Co-authorship network of co-authors of Abraham Avigdor

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Avigdor. A scholar is included among the top collaborators of Abraham Avigdor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Avigdor. Abraham Avigdor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Danylesko, Ivetta, Noga Shem‐Tov, Ronit Yerushalmi, et al.. (2024). Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression. Current Research in Translational Medicine. 72(4). 103471–103471. 5 indexed citations

Fraser, Graeme, Paula Cramer, Fatih Demırkan, et al.. (2016). IBRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): 2-YEAR FOLLOW-UP INCLUDING MRD FROM THE HELIOS STUDY. Haematologica. 101. 150–151. 4 indexed citations

Gafter‐Gvili, Anat, Elena Ribakovsky, Abraham Avigdor, et al.. (2015). Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study. Leukemia & lymphoma. 57(1). 63–69. 23 indexed citations

Orlovsky, Kira, Alexander Kalinkovich, Tanya Rozovskaia, et al.. (2011). Down-regulation of homeobox genes MEIS1 and HOXA in MLL -rearranged acute leukemia impairs engraftment and reduces proliferation. Proceedings of the National Academy of Sciences. 108(19). 7956–7961. 47 indexed citations

Davidson, Tima, Orly Goitein, Abraham Avigdor, S. Tzila Zwas, & Elinor Goshen. (2009). 18F- FDG-PET/CT for the diagnosis of tumor thrombosis.. PubMed. 11(2). 69–73. 45 indexed citations

Goshen, Elinor, et al.. (2008). PET/CT in the Evaluation of Lymphoma in Patients With HIV-1 With Suppressed Viral Loads. Clinical Nuclear Medicine. 33(9). 610–614. 22 indexed citations

Natkunam, Yasodha, Pedro Farinha, Eric D. Hsi, et al.. (2007). LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab. Journal of Clinical Oncology. 26(3). 447–454. 133 indexed citations

Yeshurun, Moshe, et al.. (2005). Allogeneic stem-cell transplantation in patients with AML and MDS using myeloablative versus reduced-intensity doses of intravenous busulfan (Busulfex): The role of dose intensity. Biology of Blood and Marrow Transplantation. 11(2). 59–59. 1 indexed citations

Shimoni, Avichai, Moshe Yeshurun, Izhar Hardan, et al.. (2004). Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced. Biology of Blood and Marrow Transplantation. 10(7). 484–493. 38 indexed citations

10.

Shimoni, Avichai, Bella Bielorai, Amos Toren, et al.. (2003). Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity. Experimental Hematology. 31(5). 428–434. 18 indexed citations

11.

Apter, Sara, Abraham Avigdor, Gabriela Gayer, et al.. (2002). Calcification in Lymphoma Occurring Before Therapy. American Journal of Roentgenology. 178(4). 935–938. 32 indexed citations

12.

Avigdor, Abraham, et al.. (2001). Extramedullary Progression Despite a Good Response in the Bone Marrow in Patients Treated with Thalidomide for Multiple Myeloma. Leukemia & lymphoma. 42(4). 683–687. 37 indexed citations

13.

Raanani, Pia, Eran Segal, Itai Levi, et al.. (2000). Diffuse Alveolar Hemorrhage in Acute Promyelocytic Leukemia Patients Treated with ATRA - A Manifestation of the Basic Disease or the Treatment. Leukemia & lymphoma. 37(5-6). 605–610. 20 indexed citations

14.

Avigdor, Abraham, Izhar Hardan, Ofer Shpilberg, et al.. (2000). [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].. PubMed. 139(5-6). 174–9, 248, 247. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact